{
    "2021-08-16": [
        [
            {
                "time": "2021",
                "original_text": "2021年中国医药流通行业区域竞争格局分析 广东在多个市场处于领先【组图】",
                "features": {
                    "keywords": [
                        "医药流通",
                        "区域竞争",
                        "广东",
                        "领先"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医疗服务三问三答 何时会出现板块性机会？",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医疗服务",
                        "板块性机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-09 - 2021-08-13",
                "original_text": "【兴业医药】坚守大赛道龙头，寻找“专精特新”小龙头 - 医药行业周报（2021.08.09.-2021.08.13）",
                "features": {
                    "keywords": [
                        "专精特新",
                        "小龙头",
                        "医药行业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "皓元医药",
                        "诺泰生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021",
                "original_text": "【国元医药|点评】长春高新2021年中报点评：生长激素维持高速增长，疫苗板块未来可期",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "疫苗板块",
                        "高速增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}